We studied the possible association between patient age and sex, clinical presentation, Streptococcus pneumoniae serotype, antimicrobial resistance, and death in invasive pneumococcal disease cases reported by 17 European countries during 2010. The study sample comprised 2,921 patients, of whom 56.8% were men and 38.2% were >65 years of age. Meningitis occurred in 18.5% of cases. Death was reported in 264 (9.0%) cases. Older age, meningitis, and nonsusceptibility to penicillin were signifcantly asso ciated with death. Non-pneumococcal conjugate vaccine (PCV) serotypes among children <5 years of age and 7-va- lent PCV serotypes among persons 5-64 years of age were associated with increased risk for death; among adults >65 years of age, risk did not differ by serotype. These fndings highlight differences in case-fatality rates between sero types and age; thus, continued epidemiologic surveillance across all ages is crucial to monitor the long-term effects of PCVs.

Risk factors for death from invasive pneumococcal disease, europe, 2010

LOPALCO, PIETRO LUIGI;
2015-01-01

Abstract

We studied the possible association between patient age and sex, clinical presentation, Streptococcus pneumoniae serotype, antimicrobial resistance, and death in invasive pneumococcal disease cases reported by 17 European countries during 2010. The study sample comprised 2,921 patients, of whom 56.8% were men and 38.2% were >65 years of age. Meningitis occurred in 18.5% of cases. Death was reported in 264 (9.0%) cases. Older age, meningitis, and nonsusceptibility to penicillin were signifcantly asso ciated with death. Non-pneumococcal conjugate vaccine (PCV) serotypes among children <5 years of age and 7-va- lent PCV serotypes among persons 5-64 years of age were associated with increased risk for death; among adults >65 years of age, risk did not differ by serotype. These fndings highlight differences in case-fatality rates between sero types and age; thus, continued epidemiologic surveillance across all ages is crucial to monitor the long-term effects of PCVs.
2015
Navarro Torné, Adoración; Dias, Joana Gomes; Hruba, Frantiska; Lopalco, PIETRO LUIGI; Pastore Celentano, Lucia; Amato Gauci, Andrew J.; Sabbe, Martine; Detcheva, Antoaneta; Georgieva, Teodora; Bagatzouni, Despo Pieridou; Křížová, Pavla; Valentiner Branth, Palle; Fenoll, Asunción; Virolainen Julkunen, Anni; Georgakopoulou, Theano; Tzanakaki, Georgina; Melles, Márta; Vickers, Imelda; Cotter, Suzanne; Humphreys, Hilary; Kristinsson, Karl G; Caporali, Maria Grazia; D’Ancona, Fortunato Paolo; Iannazzo, Stefania; Pantosti, Annalisa; Galajeva, Jelena; Caruana, Paul; Melillo, Jackie Maistre; Fenech, Tanya Melillo; De Melker, Hester; Knol, Mirjam; Van Der Ende, Arie; Steinbakk, Martin; Vestrheim, Didrik F; Hryniewicz, Waleria; Kuch, Alicja; Paradowska Stankiewicz, Iwona; Skoczynska, Anna; Pana, Marina; Henriques Normak, Birgitta; Kraigher, Alenka; Sočan, Maja; Hupkova, Helena; Macdonald, Eisin; Slack, Mary P. E.; Waight, Pauline A.
File in questo prodotto:
File Dimensione Formato  
2015 EID.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Creative commons
Dimensione 571.28 kB
Formato Adobe PDF
571.28 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/800497
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 36
social impact